ABT
Stock Details
ABT is Abbott Laboratories's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 106.60$. Average daily volumn in 3 months 4.98M. Market cap 170.39B
Stock symbol : ABT. Exchange : NYSE. Currency : USD Lastest price : 98.04$. Total volume : 792.93k. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Abbott Laboratories (ABT)
Last Price
98.04$Change
0.17Volume
792.93k
| Previous Close | 97.87 |
| Open | 98.17 |
| Day Range | 97.68-98.41 |
| Bid | 97.99 x 1k |
| Ask | 98.00 x 900 |
| Volume | 792.93k |
| Average Volume | 4.98M |
| Market Cap | 170.39B |
| Beta | 0.67 |
| 52 Week Range | 93.25-124.36 |
| Trailing P/E | 25.07 |
| Foward P/E | 20.26 |
| Dividend (Yield %) | 2.08% |
| Ex-Dividend Date | 2023-04-13 |
Financial Details
Organization
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecologi... cal disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Market Cap:
170.39BRevenue:
43.65BTotal Assets:
74.44BTotal Cash:
9.88B
News about "Abbott Laboratories"
Peering Into Abbott Laboratories's Recent Short Interest
Source from : Benzinga on MSN - 5 days ago
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 5.13% since its last report. The company recently reported that it has 13.93 million shares sold short, which is 0.82% of all regular ...See details»
Abbott Laboratories (ABT): A Fresh Data-Based Analysis
Source from : stocksregister - 4 days ago
Abbott Laboratories (NYSE:ABT) price on Friday, March 17, fall -2.04% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $97.01. A look at the stock’s price ...See details»
Abbott Laboratories stock rises Tuesday, still underperforms market
Source from : MarketWatch - 7 days ago
Shares of Abbott Laboratories inched 0.37% higher to $98.55 Tuesday, on what proved to be an all-around favorable trading session for the stock market, ...See details»
Abbott (ABT) to Pair CGM Sensors & AID System on FDA Clearance
Source from : Zacks.com on MSN - 8 days ago
Abbott Laboratories ABT recently announced that its modified continuous glucose monitoring (CGM) system sensors, FreeStyle Libre 2 and FreeStyle Libre 3, have received FDA clearance for integration ...See details»
Abbott faces SEC investigation over infant formula debacle
Source from : CBS News - 29 days ago
Abbott Laboratories is facing investigations by the Securities and Exchange Commission and the Federal Trade Commission (FTC) in connection with its formula business, the company revealed in a ...See details»
Abbott Laboratories
Source from : Fortune - 4 years ago
The health care company manufactures medical devices, diagnostic tools, branded generic pharmaceuticals, and nutritional products like Ensure. © 2023 Fortune Media ...See details»
PAC Profile: Abbott Laboratories
Source from : OpenSecrets.org - 4 days ago
*Based on data released by the Federal Election Commission on March 17, 2023 except for independent expenditure and communication cost, contributions to federal candidates, and contributions from ...See details»
Abbott Laboratories (NYSE:ABT) Is Down -10.24% Year To Date; Analysts Say It Will Rally
Source from : stocksregister - 6 days ago
Abbott Laboratories (NYSE:ABT) price closed higher on Tuesday, March 14, jumping 0.37% above its previous close. A look at the daily price movement shows that the last close reads $98.19, with ...See details»
Abbott Laboratories (ABT) Stock: A Study of the Market Performance
Source from : newsheater - 7 days ago
The stock of Abbott Laboratories (ABT) has seen a -4.44% decrease in the past week, with a -9.14% drop in the past month, and a -8.16% decrease in the past quarter. The volatility ratio for the week ...See details»
Abbott gets FTC notice for information on infant formula products
Source from : Reuters - 1 month ago
Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid Feb 17 (Reuters) - Abbott Laboratories ...See details»
ABBOTT LABORATORIES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Abbott Laboratories - ABT
Source from : newsroom.businesswire.com - 17 days ago
Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Abbott Laboratories (NYSE: ABT). In early 2022, the Company ...See details»
abbott labs
Source from : WTVD - 2 years ago
FDA probes accuracy issue with Abbott's rapid COVID-19 test Health officials have been alerting doctors to the potential inaccuracy in the test, which is used at thousands of testing sites across ...See details»
Abbott (ABT) Reveals Favorable Data on Tricuspid Regurgitation
Source from : Yahoo Finance - 13 days ago
Abbott Laboratories ABT recently announced late-breaking data on the company’s TriClip transcatheter edge-to-edge repair (TEER) system. This is a first-of-its-kind minimally invasive device ...See details»
Abbott Laboratories Pakistan Ltd.
Source from : Wall Street Journal - 4 days ago
1 Day ABOT -2.70% DJIA -1.19% S&P 500 -1.10% Health Care/Life Sciences -0.93% ...See details»